The North America API Intermediate Market would witness market growth of 6.5% CAGR during the forecast period (2023-2030).
Active pharmaceutical ingredients (APIs), the essential elements of pharmaceutical medications, are synthesized from chemical molecules known as intermediates, also referred to as active pharmaceutical ingredient intermediates. These intermediates have a variety of uses and are essential to the pharmaceutical manufacturing process. The development stage of novel pharmaceutical substances makes use of API intermediates. API intermediates' precursor molecules or building blocks are used to create APIs. In quality control processes, API intermediates are used as reference standards.
The increase in the number of elderly populations, the rise in chronic illness populations, and the prominence of market participants are the main factors driving the expansion of the market size. For instance, API intermediates manufacture medications for diabetes, gastrointestinal, lung disease, anti-cancer, anti-histamine, anti-psychotic, and anti-diabetic conditions. Thus, it is projected that increasing rates of chronic illnesses like cancer, cardiac diseases, respiratory disorders, and orthopaedic diseases will propel market expansion.
Lung cancer has been diagnosed in the majority of patients in the last five years. In the United States, tens of thousands of people are treated for non- small cell lung cancer (NSCLC) each year. As a result of the rising prevalence of lung cancer, the market is predicted to rise. Based on Canadian Cancer Statistics, 43% of Canadian women and 45% of Canadian men will develop cancer during their lifetime. The number of new cancer cases continues to rise steadily as the Canadian population grows and ages. Also, the prevalence of other chronic conditions is rising in the regional nations. With this rising number of cancer cases, the need for items such as API intermediate would grow, thereby leading to regional market growth.
The US market dominated the North America API Intermediate Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $50.6 billion by 2030. The Canada market is poised to grow at a CAGR of 8.9% during (2023 - 2030). Additionally, The Mexico market would witness a CAGR of 8% during (2023 - 2030).
Based on Type, the market is segmented into Bulk Drug Intermediates, and Chemical Intermediates. Based on End User, the market is segmented into Biotech & Pharmaceutical Companies, CMO, and Others. Based on Application, the market is segmented into Analgesics, Antidiabetic Drugs, Anti-Infective Drugs, Cardiovascular Drugs, Anticancer Drugs, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Worldwide API Intermediate Market is Projected to reach USD 237.7 Billion by 2030, at a CAGR of 7.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Cation Pharma, Espee Group, Sandoo Pharmaceuticals and Chemicals Co., Ltd., Cipla Limited, Cambrex Corporation, Vertellus, Dr. Reddy’s Laboratories Ltd., Evonik Industries AG (RAG-Stiftung), Pfizer, Inc., Shree Ganesh Remedies Limited.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Bulk Drug Intermediates
- Chemical Intermediates
By End User
- Biotech & Pharmaceutical Companies
- CMO
- Others
By Application
- Analgesics
- Antidiabetic Drugs
- Anti-Infective Drugs
- Cardiovascular Drugs
- Anticancer Drugs
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Cation Pharma
- Espee Group
- Sandoo Pharmaceuticals and Chemicals Co., Ltd.
- Cipla Limited
- Cambrex Corporation
- Vertellus
- Dr.Reddy’s Laboratories Ltd.
- Evonik Industries AG (RAG-Stiftung)
- Pfizer, Inc.
- Shree Ganesh Remedies Limited
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America API Intermediate Market, by Type
1.4.2 North America API Intermediate Market, by End User
1.4.3 North America API Intermediate Market, by Application
1.4.4 North America API Intermediate Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis
Chapter 4. Strategies Deployed in API Intermediate Market
Chapter 5. North America API Intermediate Market by Type
5.1 North America Bulk Drug Intermediates Market by Country
5.2 North America Chemical Intermediates Market by Country
Chapter 6. North America API Intermediate Market by End User
6.1 North America Biotech & Pharmaceutical Companies Market by Country
6.2 North America CMO Market by Country
6.3 North America Others Market by Country
Chapter 7. North America API Intermediate Market by Application
7.1 North America Analgesics Market by Country
7.2 North America Antidiabetic Drugs Market by Country
7.3 North America Anti-Infective Drugs Market by Country
7.4 North America Cardiovascular Drugs Market by Country
7.5 North America Anticancer Drugs Market by Country
7.6 North America Others Market by Country
Chapter 8. North America API Intermediate Market by Country
8.1 US API Intermediate Market
8.1.1 US API Intermediate Market by Type
8.1.2 US API Intermediate Market by End User
8.1.3 US API Intermediate Market by Application
8.2 Canada API Intermediate Market
8.2.1 Canada API Intermediate Market by Type
8.2.2 Canada API Intermediate Market by End User
8.2.3 Canada API Intermediate Market by Application
8.3 Mexico API Intermediate Market
8.3.1 Mexico API Intermediate Market by Type
8.3.2 Mexico API Intermediate Market by End User
8.3.3 Mexico API Intermediate Market by Application
8.4 Rest of North America API Intermediate Market
8.4.1 Rest of North America API Intermediate Market by Type
8.4.2 Rest of North America API Intermediate Market by End User
8.4.3 Rest of North America API Intermediate Market by Application
Chapter 9. Company Profiles
9.1 Cation Pharma
9.1.1 Company Overview
9.1.2 SWOT Analysis
9.2 Espee Group
9.2.1 Company Overview
9.2.2 Recent strategies and developments:
9.2.2.1 Trials and Approvals:
9.3 Sandoo Pharmaceuticals and Chemicals Co., Ltd.
9.3.1 Company Overview
9.3.2 SWOT Analysis
9.4 Cipla Limited
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional Analysis
9.4.4 Research & Development Expense
9.4.5 SWOT Analysis
9.5 Cambrex Corporation
9.5.1 Company Overview
9.5.2 Recent strategies and developments:
9.5.2.1 Acquisition and Mergers:
9.5.3 SWOT Analysis
9.6 Vertellus
9.6.1 Company Overview
9.6.2 SWOT Analysis
9.7 Dr. Reddy’s Laboratories Ltd.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.6 SWOT Analysis
9.8 Evonik Industries AG (RAG-Stiftung)
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 Recent strategies and developments:
9.8.5.1 Partnerships, Collaborations, and Agreements:
9.8.5.2 Geographical Expansions:
9.8.6 SWOT Analysis
9.9 Pfizer, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional & Segmental Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Geographical Expansions:
9.9.6 SWOT Analysis
9.10. SHREE GANESH REMEDIES LIMITED
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 SWOT Analysis
TABLE 1 North America API Intermediate Market, 2019 - 2022, USD Million
TABLE 2 North America API Intermediate Market, 2023 - 2030, USD Million
TABLE 3 North America API Intermediate Market by Type, 2019 - 2022, USD Million
TABLE 4 North America API Intermediate Market by Type, 2023 - 2030, USD Million
TABLE 5 North America Bulk Drug Intermediates Market by Country, 2019 - 2022, USD Million
TABLE 6 North America Bulk Drug Intermediates Market by Country, 2023 - 2030, USD Million
TABLE 7 North America Chemical Intermediates Market by Country, 2019 - 2022, USD Million
TABLE 8 North America Chemical Intermediates Market by Country, 2023 - 2030, USD Million
TABLE 9 North America API Intermediate Market by End User, 2019 - 2022, USD Million
TABLE 10 North America API Intermediate Market by End User, 2023 - 2030, USD Million
TABLE 11 North America Biotech & Pharmaceutical Companies Market by Country, 2019 - 2022, USD Million
TABLE 12 North America Biotech & Pharmaceutical Companies Market by Country, 2023 - 2030, USD Million
TABLE 13 North America CMO Market by Country, 2019 - 2022, USD Million
TABLE 14 North America CMO Market by Country, 2023 - 2030, USD Million
TABLE 15 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 16 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 17 North America API Intermediate Market by Application, 2019 - 2022, USD Million
TABLE 18 North America API Intermediate Market by Application, 2023 - 2030, USD Million
TABLE 19 North America Analgesics Market by Country, 2019 - 2022, USD Million
TABLE 20 North America Analgesics Market by Country, 2023 - 2030, USD Million
TABLE 21 North America Antidiabetic Drugs Market by Country, 2019 - 2022, USD Million
TABLE 22 North America Antidiabetic Drugs Market by Country, 2023 - 2030, USD Million
TABLE 23 North America Anti-Infective Drugs Market by Country, 2019 - 2022, USD Million
TABLE 24 North America Anti-Infective Drugs Market by Country, 2023 - 2030, USD Million
TABLE 25 North America Cardiovascular Drugs Market by Country, 2019 - 2022, USD Million
TABLE 26 North America Cardiovascular Drugs Market by Country, 2023 - 2030, USD Million
TABLE 27 North America Anticancer Drugs Market by Country, 2019 - 2022, USD Million
TABLE 28 North America Anticancer Drugs Market by Country, 2023 - 2030, USD Million
TABLE 29 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 30 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 31 North America API Intermediate Market by Country, 2019 - 2022, USD Million
TABLE 32 North America API Intermediate Market by Country, 2023 - 2030, USD Million
TABLE 33 US API Intermediate Market, 2019 - 2022, USD Million
TABLE 34 US API Intermediate Market, 2023 - 2030, USD Million
TABLE 35 US API Intermediate Market by Type, 2019 - 2022, USD Million
TABLE 36 US API Intermediate Market by Type, 2023 - 2030, USD Million
TABLE 37 US API Intermediate Market by End User, 2019 - 2022, USD Million
TABLE 38 US API Intermediate Market by End User, 2023 - 2030, USD Million
TABLE 39 US API Intermediate Market by Application, 2019 - 2022, USD Million
TABLE 40 US API Intermediate Market by Application, 2023 - 2030, USD Million
TABLE 41 Canada API Intermediate Market, 2019 - 2022, USD Million
TABLE 42 Canada API Intermediate Market, 2023 - 2030, USD Million
TABLE 43 Canada API Intermediate Market by Type, 2019 - 2022, USD Million
TABLE 44 Canada API Intermediate Market by Type, 2023 - 2030, USD Million
TABLE 45 Canada API Intermediate Market by End User, 2019 - 2022, USD Million
TABLE 46 Canada API Intermediate Market by End User, 2023 - 2030, USD Million
TABLE 47 Canada API Intermediate Market by Application, 2019 - 2022, USD Million
TABLE 48 Canada API Intermediate Market by Application, 2023 - 2030, USD Million
TABLE 49 Mexico API Intermediate Market, 2019 - 2022, USD Million
TABLE 50 Mexico API Intermediate Market, 2023 - 2030, USD Million
TABLE 51 Mexico API Intermediate Market by Type, 2019 - 2022, USD Million
TABLE 52 Mexico API Intermediate Market by Type, 2023 - 2030, USD Million
TABLE 53 Mexico API Intermediate Market by End User, 2019 - 2022, USD Million
TABLE 54 Mexico API Intermediate Market by End User, 2023 - 2030, USD Million
TABLE 55 Mexico API Intermediate Market by Application, 2019 - 2022, USD Million
TABLE 56 Mexico API Intermediate Market by Application, 2023 - 2030, USD Million
TABLE 57 Rest of North America API Intermediate Market, 2019 - 2022, USD Million
TABLE 58 Rest of North America API Intermediate Market, 2023 - 2030, USD Million
TABLE 59 Rest of North America API Intermediate Market by Type, 2019 - 2022, USD Million
TABLE 60 Rest of North America API Intermediate Market by Type, 2023 - 2030, USD Million
TABLE 61 Rest of North America API Intermediate Market by End User, 2019 - 2022, USD Million
TABLE 62 Rest of North America API Intermediate Market by End User, 2023 - 2030, USD Million
TABLE 63 Rest of North America API Intermediate Market by Application, 2019 - 2022, USD Million
TABLE 64 Rest of North America API Intermediate Market by Application, 2023 - 2030, USD Million
TABLE 65 Key Information – Cation Pharma
TABLE 66 Key Information – Espee Group
TABLE 67 Key Information – Sandoo Pharmaceuticals and Chemicals Co., Ltd.
TABLE 68 Key Information – Cipla Limited
TABLE 69 Key Information – Cambrex Corporation
TABLE 70 Key Information – Vertellus
TABLE 71 key information – Dr. Reddy’s Laboratories Ltd.
TABLE 72 Key Information – Evonik Industries AG
TABLE 73 Key Information – Pfizer, Inc.
TABLE 74 Key Information – SHREE GANESH REMEDIES LIMITED
List of Figures
FIG 1 Methodology for the research
FIG 2 North America API Intermediate Market, 2019 - 2030, USD Million
FIG 3 Key Impacting Factors API intermediate market
FIG 4 Porter’s Five Forces Analysis – API Intermediate Market
FIG 5 North America API Intermediate Market share by Type, 2022
FIG 6 North America API Intermediate Market share by Type, 2030
FIG 7 North America API Intermediate Market by Type, 2019 - 2030, USD Million
FIG 8 North America API Intermediate Market share by End User, 2022
FIG 9 North America API Intermediate Market share by End User, 2030
FIG 10 North America API Intermediate Market by End User, 2019 - 2030, USD Million
FIG 11 North America API Intermediate Market share by Application, 2022
FIG 12 North America API Intermediate Market share by Application, 2030
FIG 13 North America API Intermediate Market by Application, 2019 - 2030, USD Million
FIG 14 North America API Intermediate Market share by Country, 2022
FIG 15 North America API Intermediate Market share by Country, 2030
FIG 16 North America API Intermediate Market by Country, 2019 - 2030, USD Million
FIG 17 Swot Analysis: Cation Pharma
FIG 18 Swot Analysis: Sandoo Pharmaceuticals and Chemicals Co., Ltd.
FIG 19 SWOT Analysis: Cipla Limited
FIG 20 Swot Analysis: Cambrex Corporation
FIG 21 Swot Analysis: Vertellus
FIG 22 Swot Analysis: Dr. Reddy’s Laboratories Ltd.
FIG 23 Recent strategies and developments: Evonik Industries AG
FIG 24 Swot Analysis: Evonik Industries AG
FIG 25 Swot Analysis: Pfizer, Inc.
FIG 26 Swot Analysis: SHREE GANESH REMEDIES LIMITED